RU2001127714A - RADIOACTIVE CISPLATIN FOR CANCER TREATMENT - Google Patents
RADIOACTIVE CISPLATIN FOR CANCER TREATMENTInfo
- Publication number
- RU2001127714A RU2001127714A RU2001127714/14A RU2001127714A RU2001127714A RU 2001127714 A RU2001127714 A RU 2001127714A RU 2001127714/14 A RU2001127714/14 A RU 2001127714/14A RU 2001127714 A RU2001127714 A RU 2001127714A RU 2001127714 A RU2001127714 A RU 2001127714A
- Authority
- RU
- Russia
- Prior art keywords
- cisplatin
- radioactive
- cancer treatment
- radioactive cisplatin
- use according
- Prior art date
Links
- 229960004316 cisplatin Drugs 0.000 title claims 8
- LXZZYRPGZAFOLE-UHFFFAOYSA-L transplatin Chemical compound [H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H] LXZZYRPGZAFOLE-UHFFFAOYSA-L 0.000 title claims 8
- 230000002285 radioactive Effects 0.000 title claims 4
- 201000011510 cancer Diseases 0.000 title claims 2
- 230000036740 Metabolism Effects 0.000 claims 1
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 claims 1
- 230000035786 metabolism Effects 0.000 claims 1
Claims (5)
Publications (1)
Publication Number | Publication Date |
---|---|
RU2001127714A true RU2001127714A (en) | 2003-07-10 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0300421A2 (en) | Method of treatment using ligand-immunogen conjugates | |
MY129512A (en) | Novel medicament compositions, based on tiotropium bromide and salmeterol | |
RU98111594A (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING FLURBIPROFEN | |
RU2001128504A (en) | Growth promoting compositions | |
JP2005515966A5 (en) | ||
TR200100931T2 (en) | New sustained release oral formulations | |
JP2005518433A5 (en) | ||
SG167657A1 (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
JP2005507892A5 (en) | ||
CA2150184A1 (en) | Pharmaceutical composition for the treatment of inflammatory bowel diseases | |
WO2001017517A3 (en) | Use of g(a)-linolenic acid metabolites in the manufacture of a medicament for the treatment or prevention of cancer | |
JP2009516719A5 (en) | ||
JP2006516571A5 (en) | ||
WO2003049694A3 (en) | Methods of therapy for non-hodgkin's lymphoma | |
ATE257704T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING NORASTEMIZOLE. | |
RU2002121546A (en) | SUBSTANCES FOR THE TREATMENT OF PSORIASIS | |
ATE290858T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING N-PALMITOYLETHANOLAMIDE AND THEIR USE IN VETERINARY MEDICINE | |
JP2002544227A5 (en) | ||
JP2003514025A5 (en) | ||
WO2001074365A3 (en) | An efficacious dosage regimen of galantamine that reduces side effects | |
CA2150183A1 (en) | Pharmaceutical composition for the treatment of hemorrhoidal diseases | |
JP2006504735A5 (en) | Composition for the treatment of chronic pelvic pain syndrome comprising chorionic gonadotropin | |
PE20031047A1 (en) | TREATMENT OF POST-MENOPAUSAL PATIENTS IN PATIENTS WITH BREAST CANCER | |
CA2435921A1 (en) | Method of cancer therapy | |
RU2001127714A (en) | RADIOACTIVE CISPLATIN FOR CANCER TREATMENT |